KalVista Pharmaceuticals
KALV
KALV
94 hedge funds and large institutions have $357M invested in KalVista Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 31
Holders
94
Holding in Top 10
3
Calls
$9.88M
Puts
–
Top Buyers
| 1 | +$7.68M | |
| 2 | +$5.48M | |
| 3 | +$4.53M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$4.45M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$4.01M |
Top Sellers
| 1 | -$4.85M | |
| 2 | -$4.22M | |
| 3 | -$3.21M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$1.78M |
| 5 |
Renaissance Technologies
New York
|
-$1.53M |